VANCOUVER, BC – Acuitas Therapeutics, Inc. was recently named one of BC’s Top Employers of 2024. The Vancouver-based, privately held biotechnology firm is the global leader in the development of… Read More
Approval is based on the Phase 3 KEYNOTE-811 Trial KIRKLAND, QC – Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that Health Canada has granted… Read More
HTuO Biosciences, a computational drug discovery biotechnology company, is pleased to announce joining Johnson & Johnson Innovation – JLABS VANCOUVER, BC – HTuO Biosciences, a biotechnology company developing an innovative molecular… Read More
The Cardiac Auscultation monitoring device was trialed for use with heart failure patients as an adjunct to care in monitoring the effectiveness of congestive heart failure medication management The limited… Read More
Gilead Adds Seladelpar to Portfolio, a PPARδ Agonist for the Treatment of Primary Biliary Cholangitis (PBC) with FDA Priority Review and Anticipated U.S. Approval in Third Quarter of 2024 Seladelpar… Read More
